Harnessing the power of immuno-metabolism.
Reigniting the immune system to attack cancer by disrupting suppressive metabolic pathways
Learn more

Reigniting the immune system to attack cancer by disrupting suppressive metabolic pathways

Learn more
Kyn Therapeutics is developing cancer therapies focused on metabolic pathways that influence the innate and adaptive immune systems.

Stimulating a strong and broad immune response

By harnessing immuno- metabolic networks, we’re engaging a broad range of immune cell types to improve efficacy and patient response in a wide range of cancer types.

Learn more

Common characteristics of an immunosuppressive tumor microenvironment

Increased:

  • Secretion of immunosuppressive molecules
  • Generation of immunosuppressive metabolites
  • Infiltration of regulatory immune cells
  • Incidence of anergic effector T cells

Decreased:

  • Expression of immune-activating molecules
  • Penetration of proinflammatory helper and effector immune cells
  • Tumor antigen presentation

Overcoming local tumor defenses

At Kyn, we are focused on enhancing immunity and breaking down the broad range of cancer defenses so immune cells can reach and eradicate the tumor.

Learn more

Our pipeline

The Kyn Therapeutics pipeline addresses three distinct immuno-metabolic targets. Each of these programs target key metabolites in highly characterized pathways that drive immunosuppression in numerous cancer types.

Learn more

Twitter

@KynTherapeutics
The amount of #immunooncology drugs in the pipeline is rapidly growing, with more than 2,000 clinical trials underw… http://J6CyeO4DmM

view all Tweets

Alerts

Sign up to get up-to-date news about Kyn Therapeutics.

Contact us

Find us

Kyn Therapeutics
50 Northern Avenue
7th Floor
Boston, MA 02210

Call us

1-857-273-8343

Email us

info@kyntherapeutics.com

Friend us

LinkedIn